nach oben

Current Infectious Disease Reports

Erschienen in:

01.10.2011

What’s New in the Management of Bacterial Septic Arthritis?

verfasst von: Sumeet Chander, Gerald Coakley

Erschienen in: Current Infectious Disease Reports | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Septic arthritis is a common rheumatological emergency requiring prompt diagnosis and treatment, since delays in management can lead to high morbidity and mortality. In this review article, we discuss the epidemiology and recent advances in knowledge of the pathogenesis of septic arthritis, with a special emphasis on various bacterial and host factors involved in mediating the inflammatory process and the potential for targeted therapy to modulate the immune response. Recent advances in laboratory and imaging techniques are reviewed along with treatment and potential new therapies.

Gupta MN, Sturrock RD, Field M. A prospective 2 year study of 75 patients with adult-onset septic arthritis. Rheumatology. 2001;40(1):24–30.PubMedCrossRef

Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect. 1996;117:423–8.PubMedCrossRef

Kaandorp CJE, Dinant HJ, van de Laar MAFJ, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997;56(8):470–5.PubMedCrossRef

Weston VC, Jones AC, Bradbury N, et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis. 1999;58(4):214–9.PubMedCrossRef

Nade S. Septic arthritis. Best Pract Res Clin Rheumatol. 2003;17(2):183–200.PubMedCrossRef

• Favero M, Schiavon F, Riato L, et al. Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings. Autoimmun Rev. 2008;8(1):59–61. Outlines rheumatoid arthritis as a risk factor for septic arthritis.PubMedCrossRef

Smith JW, Chalupa P, Shabaz Hasan M. Infectious arthritis: clinical features, laboratory findings and treatment. Clin Microbiol Infect. 2006;12(4):309–14.PubMedCrossRef

Weng C-T, Liu M-F, Lin L-H, et al. Rare coexistence of gouty and septic arthritis: a report of 14 cases. Clin Exp Rheumatol. 2009;27(6):902–6.PubMed

•• Allison DC, Holtom PD, Patzakis MJ, Zalavras CG. Microbiology of bone and joint infections in injecting drug abusers. Clin Orthop Relat Res. 2010;468(8):2107–12. This paper shows MRSA as an important causative organism of septic arthritis.PubMedCrossRef

10.

Frazee BW, Fee C, Lambert L. How common is MRSA in adult septic arthritis? Ann Emerg Med. 2009;54(5):695–700.PubMedCrossRef

11.

Goldenberg DLM, Brandt KDM, Cathcart ESM, Cohen ASM. Acute arthritis caused by gram-negative bacilli: a clinical characterization. [Article]. Medicine. 1974;53(3):197–208.PubMedCrossRef

12.

Palmqvist N, Foster T, Tarkowski A, Josefsson E. Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog. 2002;33(5):239–49.PubMedCrossRef

13.

Swaminathan A, Massasso D, Gotis-Graham I, Gosbell I. Fulminant methicillin-sensitive Staphylococcus aureus infection in a healthy adolescent, highlighting Panton-Valentine leucocidin syndrome. Intern Med J. 2006;36(11):744–7.PubMedCrossRef

14.

Martinez-Aguilar GM, Avalos-Mishaan AM, Hulten KP, et al. Community-acquired, methicillin-resistant and methicillin-susceptible staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23(8):701–6.PubMedCrossRef

15.

•• Mathews CJ, Weston VC, Jones A, et al. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846–55. A detailed and a comprehensive overview of etiopathogenesis and management of septic arthritis.PubMedCrossRef

16.

Hultgren O, Eugster HP, Sedgwick JD, et al. TNF/Lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol. 1998;161(11):5937–42.PubMed

17.

Hultgren OH, Svensson L, Tarkowski A. Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol. 2002;168(10):5207–12.PubMed

18.

Gjertsson I, Hultgren OH, Tarkowski A. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol. 2002;130(3):409–14.PubMedCrossRef

19.

Hultgren O, Kopf M, Tarkowski A. Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host. Eur J Immunol. 1999;29(8):2400–5.PubMedCrossRef

20.

• Collins CE, La DT, Yang HT, et al. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis. 2009;68(11):1768–74. A potential new diagnostic marker for septic arthritis.PubMedCrossRef

21.

Remijsen Q, Kuijpers TW, Wirawan E, et al. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 2011;18(4):581–8.PubMedCrossRef

22.

Logters T, Paunel-Gorgulu A, Zilkens C, et al. Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis. J Orthop Res. 2009;27(11):1401–7.PubMedCrossRef

23.

•• Varoga D, Klostermeier E, Paulsen F, et al. The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and −4 are induced in synovial membranes in case of septic arthritis. Virchows Arch. 2009;454(6):685–94. This study shows an important host defence mechanism against bacteria in septic arthritis.PubMedCrossRef

24.

Papathanasiou I, Malizos KN, Poultsides L, et al. The catabolic role of toll-like receptor 2 (TLR-2) mediated by the NF-κB pathway in septic arthritis. J Orthop Res. 2011;29(2):247–51.PubMedCrossRef

25.

Puliti M, Bistoni F, Tissi L. Lack of B7-1 and B7-2 costimulatory molecules modulates the severity of group B Streptococcus-induced arthritis. Microb Infect. 2010;12(4):302–8.CrossRef

26.

Ispahani P, Weston VC, Turner DPJ, Donald FE. Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985–1998. Clin Infect Dis. 1999;29(6):1450–4.PubMedCrossRef

27.

Goldenberg DL, Cohen AS. Acute infectious arthritis. A review of patients with non-gonococcal joint infections (with emphasis on therapy and prognosis). Am J Med. 1976;60:369–77.PubMedCrossRef

28.

Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis. 2003;62(4):327–31.PubMedCrossRef

29.

Eder L, Zisman D, Rozenbaum M, Rosner I. Clinical features and aetiology of septic arthritis in northern Israel. Rheumatology. 2005;44(12):1559–63.PubMedCrossRef

30.

Coakley G, Mathews C, Field M, et al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology. 2006;45(8):1039–41.PubMedCrossRef

31.

Dubnov-Raz G, Scheuerman O, Chodick G, et al. Invasive Kingella kingae infections in children: clinical and laboratory characteristics. Pediatrics. 2008;122(6):1305–9.PubMedCrossRef

32.

•• Kim H, Kim J, Ihm C. The usefulness of multiplex PCR for the identification of bacteria in joint infection. J Clin Lab Anal. 2010;24(3):175–81. This study discusses an important new and rapid diagnostic tool for septic arthritis.PubMedCrossRef

33.

Sontakke S, Cadenas MB, Maggi RG, et al. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Meth. 2009;76(3):217–25.CrossRef

34.

• Ernst AAM, Weiss SJM, Tracy LAM, Weiss NR. Usefulness of CRP and ESR in predicting septic joints. South Med J. 2010;103(6):522–6. This paper reveals interpretation and importance of traditional inflammatory markers in septic arthritis.PubMedCrossRef

35.

Li SF, Henderson J, Dickman E, Darzynkiewicz R. Laboratory tests in adults with monoarticular arthritis: can they rule out a septic joint? Acad Emerg Med. 2004;11(3):276–80.PubMedCrossRef

36.

Hugle T, Schuetz P, Mueller B, et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol. 2008;26(3):453–6.PubMed

37.

Li SF, Cassidy C, Chang C, et al. Diagnostic utility of laboratory tests in septic arthritis. Emerg Med J. 2007;24(2):75–7.PubMedCrossRef

38.

Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA: J Am Med Assoc. 2007;297(13):1478–88.CrossRef

39.

Coutlakis PJ, Roberts WN, Wise CM. Another look at Synovial fluid leukocytosis and infection. JCR: J Clin Rheumatol. 2002;8(2):67–71.PubMedCrossRef

40.

McGillicuddy DC, Shah KH, Friedberg RP, et al. How sensitive is the synovial fluid white blood cell count in diagnosing septic arthritis? Am J Emerg Med. 2007;25(7):749–52.PubMedCrossRef

41.

Abdullah S, Young-Min SA, Hudson SJ, et al. Gross synovial fluid analysis in the differential diagnosis of joint effusion. J Clin Pathol. 2007;60(10):1144–7.PubMedCrossRef

42.

Thompson A, Mannix R, Bachur R. Acute pediatric monoarticular arthritis: distinguishing Lyme arthritis from other etiologies. Pediatrics. 2009;123:959–65.PubMedCrossRef

43.

de Murphy CA, Gemmel F, Balter J. Clinical trial of specific imaging of infections. Nucl Med Comm. 2010;31(8):726–33.CrossRef

44.

Christian S, Kraas J, Conway WF. Musculoskeletal infections. Semin Roentgenol. 2007;42(2):92–101.PubMedCrossRef

45.

• Lefevre S, Ruimy D, Jehl F, et al. Septic arthritis: monitoring with USPIO-enhanced Macrophage MR imaging. Radiology. 2011;258(3):722–8. This paper discusses a new imaging tool to diagnose and monitor response to antibiotic therapy in septic arthritis.PubMedCrossRef

46.

Ravindran V, Logan I, Bourke BE. Medical vs. surgical treatment for the native joint in septic arthritis: a 6-year, single UK academic centre experience. Rheumatology (Oxford). 2009;48:1320–2.CrossRef

47.

Stengel D, Bauwens K, Sehouli J, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis. 2001;1(3):175–88.PubMedCrossRef

48.

Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents. 2007;30(3):202–9.PubMedCrossRef

49.

Falagas ME, Siempos II, Papagelopoulos PJ, Vardakas KZ. Linezolid for the treatment of adults with bone and joint infections. Int J Antimicrob Agents. 2007;29(3):233–9.PubMedCrossRef

50.

Seaton RA. J Antimicrob Chemother. 2008;62 suppl 3:iii15–23.PubMedCrossRef

51.

Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2006;59(2):165–74.PubMedCrossRef

52.

Schelenz S, Bramham K, Goldsmith D. Septic arthritis due to extended spectrum beta lactamase producing Klebsiella pneumoniae. Joint Bone Spine. 2007;74(3):275–8.PubMedCrossRef

53.

Bean D, Krahe D, Wareham D. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob. 2008;7(1):13.PubMedCrossRef

54.

Borg MA, Sande-Bruinsma N, Scicluna E, et al. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect. 2008;14(8):789–96.PubMedCrossRef

55.

Ballock RTM, Newton POM, Evans SJM, et al. A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis. J Pediatr Orthop. 2009;29(6):636–42.PubMedCrossRef

56.

Jain S, Tittal P, Rohilla N, et al. Acute septic arthritis revisited: a prospective study in 93 patients correlating C-reactive protein levels with duration of intravenous antibiotic therapy, clinical and radiological outcomes. Eur J Orthop Surg Traumatol. 2009;19(7):447–55.CrossRef

57.

•• Harel LM, Prais DM, Bar-On EM, et al. Dexamethasone therapy for septic arthritis in children: results of a randomized double-blind Placebo-controlled study. J Pediatr Orthop. 2011;31(2):211–5. This paper discusses the role of corticosteroids in septic arthritis.PubMedCrossRef

58.

Forsman H, Andreasson E, nnheim K, et al. European Journal of Clinical Investigation 2010 Mar; Conference(var.pagings):44–5.

59.

Puliti M, von Hunolstein C, Bistoni F, et al. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-γ and interleukin-10 production. Arthritis Rheum. 2002;46(3):806–17.PubMedCrossRef

60.

• Bruins MJ, Zwiers JH, Verheyen CCPM, Wolfhagen MJHM. In vitro study of the antimicrobial effects of radiological contrast agents used in arthrography. J Bone Joint Surg Br. 2011;93-B(1):126–30. This paper discusses a potential novel adjunctive therapy for septic arthritis.CrossRef

61.

Verdrengh M, Carlsten H, Ohlsson C, Tarkowski A. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. J Orthop Res. 2007;25(3):304–10.PubMedCrossRef

Titel: What’s New in the Management of Bacterial Septic Arthritis?
verfasst von: Sumeet Chander
Gerald Coakley
Publikationsdatum: 01.10.2011
Verlag: Current Science Inc.
Erschienen in: Current Infectious Disease Reports / Ausgabe 5/2011
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-011-0201-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

13.05.2024 Chronische Herzinsuffizienz Nachrichten

Die Anlage eines interatrialen Shunts zur Reduktion des linksatrialen Drucks ist ein neuer Therapieansatz bei Herzinsuffizienz. Viele Patienten sprechen darauf an, andere jedoch nicht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Advances in the Diagnosis and Management of Pediatric Osteomyelitis

Recent Advances in the Treatment of Necrotizing Fasciitis

Antibiotic Therapy in Neonatal and Pediatric Septic Shock

Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock

Soft Tissue Infections Caused by Marine Bacterial Pathogens: Epidemiology, Diagnosis, and Management